Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

HDFC Pharma and Healthcare Fund · Regular ✕Bank of India Business Cycle Fund · Regular ✕

Growth of ₹10,000

Basics

HDFC Pharma and Healthcare FundBank of India Business Cycle Fund
CategorySectoral / ThematicSectoral / Thematic
PlanRegularRegular
Fund houseHDFCBank of India
NAV₹22.8170₹9.8300
NAV date20 Nov 202620 Nov 2026
History3.1 years2.2 years
Expense ratio2.1%2.7%
Stars★★★★★Not rated
Growth Score93.90—

Returns

HDFC Pharma and Healthcare FundBank of India Business Cycle Fund
1 month+12.87%+5.25%
3 months+6.85%+0.61%
6 months+17.20%+8.50%
YTD+32.43%+9.47%
1 year+30.73%+5.70%
3 years (CAGR)+29.16%—
5 years (CAGR)——
10 years (CAGR)——
Since launch+30.28%−0.86%

Risk

HDFC Pharma and Healthcare FundBank of India Business Cycle Fund
Volatility15.8%—
Downside volatility8.6%—
Sharpe1.44—
Sortino2.64—
Calmar1.94—
Return / risk1.85—
Deepest fall−15.07%−25.38%
Days to recover133—
Below its high+0.00%−5.84%

Against benchmark

HDFC Pharma and Healthcare FundBank of India Business Cycle Fund
Alpha+6.36%—
Beta0.97—
R²85.0%—
Up capture106.7%—
Down capture74.4%—
Tracking error6.1%—
Information ratio0.97—
Treynor0.22—

Consistency

HDFC Pharma and Healthcare FundBank of India Business Cycle Fund
Best 1-year+64.96%+11.30%
Middle 1-year+21.84%+0.57%
Worst 1-year+0.52%−14.31%
1-year periods with a loss0.0%46.3%
Middle 3-year+28.68%—
Positive months69.4%—
Best day+3.19%+4.27%
Worst day−3.62%−3.88%
Worst 5% day−1.50%−1.76%
Positive days58.1%48.4%
NAVs a year247247

SIP of ₹10,000 a month

HDFC Pharma and Healthcare FundBank of India Business Cycle Fund
5-year XIRR——
5-year value——
3-year XIRR+26.26%—
1-year XIRR+39.84%+13.94%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth